Search research articles
Contact Us
Filters
Showing results (651-660 of 1,253) with videos related to
Page
of 126
Sort By:
The American Journal of Medicine
|
November 11, 2017
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
Meena P Rao, Dragos Vinereanu, Daniel M Wojdyla, et al.
Circulation
|
September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials
M P Hudson, C B Granger, E J Topol, et al.
Circulation
|
September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I
Padma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.
American Heart Journal
|
September 10, 2010
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study
Svati H Shah, Christopher B Granger, Elizabeth R Hauser, et al.
European Heart Journal
|
May 27, 2010
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial
Kurt Huber, David R Holmes, Arnoud W van 't Hof, et al.
The American Journal of Cardiology
|
March 25, 2008
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice
Raymond T Yan, Andrew T Yan, Christopher B Granger, et al.
Atherosclerosis
|
January 10, 2014
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization
Sayanti Bhattacharya, Christopher B Granger, Damian Craig, et al.
European Heart Journal
|
August 31, 2012
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H Hohnloser, Ziad Hijazi, Laine Thomas, et al.
American Heart Journal
|
August 8, 2025
Medicare Coverage Gap Status, Adherence to Oral Anticoagulation, and Stroke Rates in Patients with Atrial Fibrillation
Josephine Harrington, Rohin K Reddy, Anthony Carnicelli, et al.
American Heart Journal
|
September 10, 2010
Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study
Joel M Gore, Eric Peterson, Alpesh Amin, et al.
Page
of 126
Search research articles
Search
Showing results (651-660 of 1,253) with videos related to
Sort By:
Page
of 126
The American Journal of Medicine
|
November 11, 2017
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
Meena P Rao, Dragos Vinereanu, Daniel M Wojdyla, et al.
Circulation
|
September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials
M P Hudson, C B Granger, E J Topol, et al.
Circulation
|
September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I
Padma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.
American Heart Journal
|
September 10, 2010
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study
Svati H Shah, Christopher B Granger, Elizabeth R Hauser, et al.
European Heart Journal
|
May 27, 2010
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial
Kurt Huber, David R Holmes, Arnoud W van 't Hof, et al.
The American Journal of Cardiology
|
March 25, 2008
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice
Raymond T Yan, Andrew T Yan, Christopher B Granger, et al.
Atherosclerosis
|
January 10, 2014
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization
Sayanti Bhattacharya, Christopher B Granger, Damian Craig, et al.
European Heart Journal
|
August 31, 2012
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H Hohnloser, Ziad Hijazi, Laine Thomas, et al.
American Heart Journal
|
August 8, 2025
Medicare Coverage Gap Status, Adherence to Oral Anticoagulation, and Stroke Rates in Patients with Atrial Fibrillation
Josephine Harrington, Rohin K Reddy, Anthony Carnicelli, et al.
American Heart Journal
|
September 10, 2010
Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study
Joel M Gore, Eric Peterson, Alpesh Amin, et al.
Page
of 126